23 results
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
of such Person under swaps, options, derivatives and other hedging agreements or arrangements that will be payable upon termination thereof (assuming
8-K
EX-2.1
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
owned Parent Subsidiary), or (vi) net cash payment obligations of such Person under swaps, options, derivatives and other hedging agreements
424B4
m6yjx1w7ve4q8l370lbt
1 Apr 21
Prospectus supplement with pricing info
4:05pm
10-K
orcpaw2wff
19 Mar 21
Annual report
4:11pm
DRS
3keluoi1c
19 Mar 21
Draft registration statement
12:00am
8-K
EX-3.2
9z3rao
9 Jun 20
Applied Molecular Transport Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
4:47pm
424B4
0grabgd nr
5 Jun 20
Prospectus supplement with pricing info
4:52pm
S-1
EX-4.1
8lfz8ufk 5ofpapaxy
18 May 20
IPO registration
4:03pm
S-1
EX-10.2
0vsssp dpc2qmmqum
18 May 20
IPO registration
4:03pm
S-1
EX-10.3
fiihite73vsxileij5
18 May 20
IPO registration
4:03pm
S-1
EX-3.4
cgdimto3eb
18 May 20
IPO registration
4:03pm
S-1
nzq3p
18 May 20
IPO registration
4:03pm
DRS/A
gnwowzf
10 Apr 20
Draft registration statement (amended)
12:00am
DRS
cr99yjgwaug0mv
13 Feb 20
Draft registration statement
12:00am